John is the EY MedTech leader for the Americas and is also the Life Sciences Leader for Financial and Accounting Transaction Advisory. John has over 20 years of experience, all in the healthcare industry, and originally joined E&Y in 1995.

John’s corporate clients include but not limited to: Medtronic, Johnson & Johnson (including DePuy), Fresenius, GE Healthcare and Bayer, and significant PE clients including, Apax, Warburg Pincus, Avista Capital, Linden and Altaris.

Prior to rejoining E&Y’s Transaction Advisory Services practice, John was CFO of a publicly traded medical technology company and was responsible for all financial and operational aspects, including capital raising and negotiating/structuring numerous collaborations and licensing arrangements, John received a B.B.A. in accounting and an M.B.A. in finance from the University of Miami.